Linked e-resources
Details
Table of Contents
Acknowledgements; Contents; Contributors; Part I Introduction; 1: Introduction: Urinary Function Alterations in Men with Prostate Cancer; Introduction; Urinary Function After Radical Prostatectomy; Anastomotic Stricture After Radical Prostatectomy; Urinary Function After Prostate Radiotherapy; Emerging Topics in Urinary Dysfunction After Prostate Cancer; Urinary Function Recovery After Prostate Cancer Ablation; Voiding Dysfunction in Men Following Focal Therapy; Voiding Dysfunction in Men with Locally Advanced Prostate Cancer; Conclusion; References.
Part II Adverse Events After Radical Prostatectomy2: Post-prostatectomy Incontinence Initial Evaluation; Post-prostatectomy Incontinence: Introduction; Incidence; Pathophysiology; Factors That Drive Treatment; Patient Risk Factors for PPI; Influence of Surgical Techniques; Evaluation of Post-prostatectomy Incontinence; General Medical History; Characterization of Incontinence and Other Lower Urinary Tract Symptoms; Physical Exam; Voiding Diaries and Questionnaires; Pad Usage and Pad Tests; Simple Diagnostic Studies; Imaging for PPI; Urodynamics; Cystoscopy; Summary; References.
3: Urinary Incontinence: Conservative and Medical Management and Injectable TherapyIntroduction; Conservative Therapy; Absorbent Products: Liners, Guards, Briefs, Underwear; Occlusive Therapy (Penile Clamps); Catheters (Condom, Urethral and Suprapubic); Behavioral Therapy (Pelvic Floor Muscle Exercises, Biofeedback, Pelvic Floor Stimulation, and Lifestyle Adjustments); Pelvic Floor Muscle Therapy (PFMT); Initiation of PFMT.
Injectable AgentsBiologics; Bovine Collagen; Collagen Efficacy; Synthetic Injectables; Durasphere®; Product Description; Specific Tips and Manufacturer's Recommendations for Injection of Durasphere; Available Literature; Coaptite®; Product Description; Specific Tips and Manufacturer's Recommendations for Injection of Coaptite; Macroplastique®; Product Description; Specific Tips and Manufacturer's Recommendations for Injection of Macroplastique®; Preparation of the Macroplastique Administration Device; Injection; Published Data.
Part II Adverse Events After Radical Prostatectomy2: Post-prostatectomy Incontinence Initial Evaluation; Post-prostatectomy Incontinence: Introduction; Incidence; Pathophysiology; Factors That Drive Treatment; Patient Risk Factors for PPI; Influence of Surgical Techniques; Evaluation of Post-prostatectomy Incontinence; General Medical History; Characterization of Incontinence and Other Lower Urinary Tract Symptoms; Physical Exam; Voiding Diaries and Questionnaires; Pad Usage and Pad Tests; Simple Diagnostic Studies; Imaging for PPI; Urodynamics; Cystoscopy; Summary; References.
3: Urinary Incontinence: Conservative and Medical Management and Injectable TherapyIntroduction; Conservative Therapy; Absorbent Products: Liners, Guards, Briefs, Underwear; Occlusive Therapy (Penile Clamps); Catheters (Condom, Urethral and Suprapubic); Behavioral Therapy (Pelvic Floor Muscle Exercises, Biofeedback, Pelvic Floor Stimulation, and Lifestyle Adjustments); Pelvic Floor Muscle Therapy (PFMT); Initiation of PFMT.
Injectable AgentsBiologics; Bovine Collagen; Collagen Efficacy; Synthetic Injectables; Durasphere®; Product Description; Specific Tips and Manufacturer's Recommendations for Injection of Durasphere; Available Literature; Coaptite®; Product Description; Specific Tips and Manufacturer's Recommendations for Injection of Coaptite; Macroplastique®; Product Description; Specific Tips and Manufacturer's Recommendations for Injection of Macroplastique®; Preparation of the Macroplastique Administration Device; Injection; Published Data.